Literature DB >> 26149588

Hymenoptera Anaphylaxis and C-kit Mutations: An Unexpected Association.

Patrizia Bonadonna1, Massimiliano Bonifacio, Carla Lombardo, Roberta Zanotti.   

Abstract

Clinical manifestations of mastocytosis in adults comprise signs and symptoms linked to mast cell (MC) activation, including anaphylaxis. Depending on MC burden, adults can be diagnosed with systemic mastocytosis, when the WHO criteria are fulfilled, or with other clonal MC disorders, characterized by MC mediator symptoms and demonstration of activating KIT mutations and/or expression of CD25 on MCs. There is a specific link between mastocytosis and hymenoptera venom allergy (HVA): the reported frequency of HVA in mastocytosis is 20-50 % and raises to 60-80 % in patients affected by indolent systemic mastocytosis without skin lesions. The presentation of HVA characterized by severe hypotension in the absence of urticarial or angioedema is typical in patient with an underlying MC disorder, even in the presence of normal baseline serum tryptase levels.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26149588     DOI: 10.1007/s11882-015-0550-0

Source DB:  PubMed          Journal:  Curr Allergy Asthma Rep        ISSN: 1529-7322            Impact factor:   4.806


  59 in total

1.  Definitions, criteria and global classification of mast cell disorders with special reference to mast cell activation syndromes: a consensus proposal.

Authors:  Peter Valent; Cem Akin; Michel Arock; Knut Brockow; Joseph H Butterfield; Melody C Carter; Mariana Castells; Luis Escribano; Karin Hartmann; Philip Lieberman; Boguslaw Nedoszytko; Alberto Orfao; Lawrence B Schwartz; Karl Sotlar; Wolfgang R Sperr; Massimo Triggiani; Rudolf Valenta; Hans-Peter Horny; Dean D Metcalfe
Journal:  Int Arch Allergy Immunol       Date:  2011-10-27       Impact factor: 2.749

2.  Demonstration of an aberrant mast-cell population with clonal markers in a subset of patients with "idiopathic" anaphylaxis.

Authors:  Cem Akin; Linda M Scott; Can N Kocabas; Nataliya Kushnir-Sukhov; Erica Brittain; Pierre Noel; Dean D Metcalfe
Journal:  Blood       Date:  2007-07-16       Impact factor: 22.113

3.  The impact of sensitive KIT D816V detection on recognition of indolent Systemic Mastocytosis.

Authors:  Giovanna De Matteis; Roberta Zanotti; Sabrina Colarossi; Caterina De Benedittis; Andrès Garcia-Montero; Massimiliano Bonifacio; Marta Sartori; Fiorenza Aprili; Beatrice Caruso; Elisa Paviati; Giuseppe Carli; Omar Perbellini; Alberto Zamò; Patrizia Bonadonna; Giovanni Pizzolo; Giancesare Guidi; Giovanni Martinelli; Simona Soverini
Journal:  Leuk Res       Date:  2014-12-06       Impact factor: 3.156

4.  Gene expression profile, pathways, and transcriptional system regulation in indolent systemic mastocytosis.

Authors:  M Niedoszytko; J N G Oude Elberink; M Bruinenberg; B Nedoszytko; J G R de Monchy; G J te Meerman; R K Weersma; A B Mulder; E Jassem; J J van Doormaal
Journal:  Allergy       Date:  2010-09-07       Impact factor: 13.146

5.  Severe life-threatening or disabling anaphylaxis in patients with systemic mastocytosis: a single-center experience.

Authors:  Friedrich Wimazal; Philipp Geissler; Patrik Shnawa; Wolfgang R Sperr; Peter Valent
Journal:  Int Arch Allergy Immunol       Date:  2011-11-25       Impact factor: 2.749

Review 6.  Bone involvement and osteoporosis in mastocytosis.

Authors:  Maurizio Rossini; Roberta Zanotti; Ombretta Viapiana; Gaia Tripi; Giovanni Orsolini; Luca Idolazzi; Patrizia Bonadonna; Donatella Schena; Luis Escribano; Silvano Adami; Davide Gatti
Journal:  Immunol Allergy Clin North Am       Date:  2014-03-13       Impact factor: 3.479

Review 7.  Mast cell activation syndromes: definition and classification.

Authors:  P Valent
Journal:  Allergy       Date:  2013-02-15       Impact factor: 13.146

8.  Immunophenotypic analysis of mast cells in mastocytosis: When and how to do it. Proposals of the Spanish Network on Mastocytosis (REMA).

Authors:  Luis Escribano; Beatriz Diaz-Agustin; Antonio López; Rosa Núñez López; Andrés García-Montero; Julia Almeida; Aranzazu Prados; Miguel Angulo; Sonia Herrero; Alberto Orfao
Journal:  Cytometry B Clin Cytom       Date:  2004-03       Impact factor: 3.058

Review 9.  Recent advances in the understanding of mastocytosis: the role of KIT mutations.

Authors:  Alberto Orfao; Andrés C Garcia-Montero; Laura Sanchez; Luis Escribano
Journal:  Br J Haematol       Date:  2007-07       Impact factor: 6.998

10.  Systemic mastocytosis with associated clonal haematological non-mast cell lineage diseases: a histopathological challenge.

Authors:  H-P Horny; K Sotlar; W R Sperr; P Valent
Journal:  J Clin Pathol       Date:  2004-06       Impact factor: 3.411

View more
  2 in total

Review 1.  Component Resolved Diagnosis in Hymenoptera Anaphylaxis.

Authors:  D Tomsitz; K Brockow
Journal:  Curr Allergy Asthma Rep       Date:  2017-06       Impact factor: 4.806

2.  Microarray-Based Detection of Allergen-Reactive IgE in Patients with Mastocytosis.

Authors:  Dubravka Smiljkovic; Renata Kiss; Christian Lupinek; Gregor Hoermann; Georg Greiner; Nadine Witzeneder; Gerhard Krajnik; Franz Trautinger; Susanne Vrtala; Irene Mittermann; Michael Kundi; Bernd Jilma; Rudolf Valenta; Wolfgang R Sperr; Peter Valent
Journal:  J Allergy Clin Immunol Pract       Date:  2020-04-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.